InsidersTradesSigma
Follow the 康拓医疗 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 康拓医疗 has published 9 reports. Market capitalisation: €2.7bn. The latest transaction was disclosed on 23 April 2026 (Sale). Among the most active insiders: 朱海龙. The full history is free.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
9 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,711 of 28,684 companies
63.1
score / 100
Value45
Quality82
FCF yld2.6%
Earn yld3.8%
EV/EBITDA20.2x
ROE12%
Gross mgn79%
Net mgn28%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 April 2026
Declarations9 total
9 of 9 declarations
About 康拓医疗
康拓医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.